Study of the Combination Therapy of Rt-PA and Eptifibatide to Treat Acute Ischemic Stroke "CLEAR-ER"


Phase 2 Results

Summary of Purpose

The primary goal of this trial is to determine if individuals with acute ischemic stroke treated with a medium dose of IV rt-PA plus IV eptifibatide started within 3 hours of symptom onset are more likely to have a better outcome than individuals treated with standard IV rt-PA alone.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 26 March 2014.

1 Jul 2009 6 May 2009 1 Oct 2012 1 Dec 2012 1 Mar 2014 27 Nov 2013
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Double Blind (Subject, Caregiver, Investigator)
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment